Welcome to our dedicated page for Aveanna Healthcare Holdings news (Ticker: AVAH), a resource for investors and traders seeking the latest updates and insights on Aveanna Healthcare Holdings stock.
Aveanna Healthcare Holdings, Inc. (AVAH) provides essential home-based healthcare services across pediatric care, adult home health, and specialized medical solutions. This page serves as the definitive source for corporate news and official announcements from one of America's leading home care providers.
Investors and industry professionals will find timely updates including earnings reports, strategic partnerships, service expansions, and regulatory developments. Our curated collection ensures access to verified press releases and market-moving information directly from the company.
Key content areas include financial performance updates, clinical service innovations, leadership changes, and industry recognition. Each announcement is carefully organized to help stakeholders track operational milestones in pediatric home nursing, hospice care advancements, and medical solutions development.
Bookmark this page for streamlined access to AVAH's latest developments in home healthcare delivery. Check regularly for updates that matter to investors monitoring the evolving landscape of value-based care and in-home medical services.
Aveanna Healthcare Holdings (NASDAQ: AVAH) reported strong Q4 2024 financial results, with revenue increasing 8.6% to $519.9 million compared to Q4 2023. The company achieved significant improvements with a net income of $29.2 million, contrasting with a $25.7 million loss in the prior year period.
Key Q4 metrics include a 15.7% increase in gross margin to $171.7 million and a 42.8% rise in Adjusted EBITDA to $55.2 million. For the full year 2024, revenue reached $2.02 billion, up 6.8% from 2023, while Adjusted EBITDA grew 31.9% to $183.6 million.
Looking ahead, Aveanna provided 2025 guidance projecting revenue between $2.10-2.12 billion and Adjusted EBITDA between $190-194 million. The company maintains a strong liquidity position with $84.3 million in cash and additional borrowing capacity through various facilities.
Aveanna Healthcare Holdings (NASDAQ: AVAH) has scheduled its fourth quarter and full year 2024 earnings release for Thursday, March 13, 2025, before market open. The company will host a conference call at 10:00 a.m. Eastern Time on the same day.
Investors can access the conference call by dialing 1-877-407-0789 (US) or 1-201-689-8562 (International). A replay will be available for one week until March 20, 2025, accessible via 1-844-512-2921 (US) or 1-412-317-6671 (International) using passcode 13750192. Additionally, a simultaneous webcast will be available on the company's Investor Relations website at ir.aveanna.com.
Aveanna Healthcare Holdings (NASDAQ: AVAH) has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco. The company's management team will deliver a presentation on January 15, 2025 at 10:30 a.m. PST, followed by one-on-one investor meetings throughout the day.
Investors and interested parties can access a live webcast of the presentation through Aveanna's Investor Relations website at ir.aveanna.com. A replay of the presentation will be available for a time after the event.
Aveanna Healthcare Holdings reported strong Q3 2024 financial results with revenue of $509.0 million, up 6.5% year-over-year. Gross margin increased 8.4% to $159.7 million, while net loss improved to $42.8 million from $102.4 million in Q3 2023. Adjusted EBITDA grew 32.2% to $47.8 million. The company raised its full-year 2024 guidance, projecting revenue of approximately $2.0 billion and Adjusted EBITDA greater than $168 million. The improved performance was attributed to better payor rates and successful cost reduction efforts.
Aveanna Healthcare Holdings (NASDAQ: AVAH) has appointed Brent Layton as a Class III director and Audit Committee member, effective November 1, 2024. Layton, currently CEO of Sharecare, brings over 20 years of healthcare leadership experience from Centene , where he served as president and COO. In his previous role, he oversaw 31 state Medicaid health plans, Ambetter, and WellCare. The appointment aims to leverage Layton's extensive experience in healthcare policy and managed care organizations to support Aveanna's strategic growth initiatives.
Aveanna Healthcare Holdings (NASDAQ: AVAH) has announced its participation in the Stephens Annual Investment Conference. The company's management team will be attending virtually on Friday, November 22, 2024. During the conference, Aveanna's executives will be hosting one-on-one meetings with investors.
This virtual attendance at the investment conference provides an opportunity for Aveanna to engage with potential investors and discuss the company's performance, strategies, and future prospects. The one-on-one format allows for more focused and personalized interactions between the company's management and interested investors.
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) has announced its schedule for releasing third quarter 2024 financial results. The company will disclose its Q3 results before the market opens on Thursday, November 7, 2024. This will be followed by a conference call at 10:00 a.m. Eastern Time on the same day.
Investors can access the conference call by dialing 1-877-407-0789 (US) or 1-201-689-8562 (international). A replay will be available three hours after the call until November 14, 2024, accessible via 1-844-512-2921 (US) or 1-412-317-6671 (international). The passcode for both the live call and replay is 13748484.
Additionally, a simultaneous webcast of the conference call will be available on the Investor Relations section of Aveanna's website at https://ir.aveanna.com/. The online replay will remain accessible for one week following the call.
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) has announced its participation in the Deutsche Bank Annual Leveraged Finance Conference on September 24, 2024, in Scottsdale, AZ. The company's management team will be hosting one-on-one investor meetings during the event.
Aveanna Healthcare, headquartered in Atlanta, Georgia, operates in 33 states across the US. The company offers a wide range of healthcare services for both pediatric and adult patients, including:
- Nursing and rehabilitation services
- Occupational nursing in schools
- Therapy services
- Day treatment centers for medically fragile patients
- Home health and hospice services
- Enteral nutrition delivery
- Case management services
- Respite healthcare services
Aveanna's services aim to provide high-quality, cost-effective alternatives to prolonged hospitalization.
Aveanna Healthcare Holdings (NASDAQ: AVAH) reported strong Q2 2024 results, with revenue increasing 7.0% to $505.0 million and Adjusted EBITDA growing 27.3% to $45.6 million compared to Q2 2023. The company's gross margin increased 1.9% to $158.3 million. Net income was $13.9 million, down from $25.6 million in the prior year period. Based on these positive results, Aveanna has raised its full-year 2024 guidance, projecting revenue greater than $1,985 million and Adjusted EBITDA exceeding $158 million. The company attributes its success to ongoing strategic transformation efforts and enhanced payor partnerships, allowing for expanded care delivery and investment in caregivers.
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) has announced the release date for its second quarter 2024 earnings report. The company will disclose its results before the market opens on Thursday, August 8, 2024. Following the release, Aveanna will host a conference call at 10:00 a.m. Eastern Time on the same day.
Investors can access the call by dialing 1-877-407-0789 (US) or 1-201-689-8562 (international). A replay will be available for a week, accessible by dialing 1-844-512-2921 (US) or 1-412-317-6671 (international) with the passcode 13746737. Additionally, a simultaneous webcast will be available on the company's Investor Relations website at https://ir.aveanna.com/.
FAQ
What is the current stock price of Aveanna Healthcare Holdings (AVAH)?
What is the market cap of Aveanna Healthcare Holdings (AVAH)?
